Zobrazeno 1 - 10
of 1 758
pro vyhledávání: '"transthyretin amyloidosis"'
Autor:
Marco Luigetti, Francesca Vitali, Angela Romano, Maria Ausilia Sciarrone, Valeria Guglielmino, Michelangelo Ardito, Andrea Sabino, Serenella Servidei, Geny Piro, Carmine Carbone, Francesca Graziani, Rosa Lillo, Pietro Manuel Ferraro, Guido Primiano
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Hereditary transthyretin (ATTRv) amyloidosis is a rare, adult-onset, progressive, multisystemic condition caused by TTR pathogenic variants. Reliable biomarkers are needed to allow early diagnosis and to monitor disease severity and progress
Externí odkaz:
https://doaj.org/article/9d4ad3a470334b5a9a72305ae28d9df3
Autor:
Daria P. Golubovskaya, Elena V. Dren’, Anastasia V. Yurkina, Tamara B. Pecherina, Olga L. Barbarash
Publikováno v:
Терапевтический архив, Vol 96, Iss 7, Pp 695-700 (2024)
Despite the presence of various signs of cardiac amyloidosis ("red flags"), the introduction into routine practice of new non-invasive diagnostic methods (Speckle Tracking technology using echocardiography, myocardial scintigraphy with technetium pyr
Externí odkaz:
https://doaj.org/article/e840a92d1d8240319fb09dcefc52b85a
Autor:
A. A. Vedernikov, E. M. Mezhonov, N. Е. Shirokov, V. A. Balina, O. M. Reitblat, D. V. Teffenberg, S. V. Shalaev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 357-366 (2024)
Progress in instrumental diagnostics, as well as increased awareness among doctors about rare diseases, is steadily leading to an increased number of patients diagnosed with cardiac amyloidosis. Regardless of amyloid formation route, cardiac damage i
Externí odkaz:
https://doaj.org/article/6bd34766cee441b8a962881a749c955a
Autor:
Fábio Fernandes, Georgina del Cisne Jadán Luzuriaga, Guilherme Wesley Peixoto da Fonseca, Edileide Barros Correia, Alzira Alves Siqueira Carvalho, Ariane Vieira Scarlatelli Macedo, Otavio Rizzi Coelho-Filho, Phillip Scheinberg, Murillo Oliveira Antunes, Pedro Vellosa Schwartzmann, Sandrigo Mangini, Wilson Marques, Marcus Vinicius Simões
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Transthyretin amyloidosis (ATTR) is a multisystem disease caused by the deposition of fibrillar protein in organs and tissues. ATTR genotypes and phenotypes are highly heterogeneous. We present data on physical signs and symptoms,
Externí odkaz:
https://doaj.org/article/13652cdb50a54f85899e744d9db684ce
Autor:
Soo Yeon An, Yujin Yang
Publikováno v:
The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-8 (2024)
Abstract Background Amyloidosis, particularly wild-type transthyretin amyloidosis (ATTRwt), is an increasingly recognized cause of heart failure with preserved ejection fraction in the aging population. The complexity of managing ATTRwt in older pati
Externí odkaz:
https://doaj.org/article/db82075c80b14504bce5929ccb9d621c
Autor:
Taha N. Qarni, Felipe J. S. Jones, Brian Drachman, Sami Khella, Janice Pieretti, Nicolas Sarmiento Bustamante, Chafic Karam
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background There are novel medications approved for the treatment of hereditary transthyretin amyloidosis (ATTRv), classified as transthyretin (TTR) stabilizers or gene silencers. While many patients may be on both classes of medications, th
Externí odkaz:
https://doaj.org/article/0a55e17ac7d74f3bbc1bd8f147199b99
Autor:
Svetlana N. Nasonova, Igor V. Zhirov, Anastasiya A. Shoshina, Yulia F. Osmolovskaya, Alexey A. Ansheles, Olga Ya. Tchaikovskaya, Svetlana V. Dobrovolskaya, Vladimir B. Sergienko, Marina A. Saidova, Sergey N. Tereshchenko, Sergey A. Boytsov
Publikováno v:
Терапевтический архив, Vol 96, Iss 4, Pp 321-329 (2024)
Aim. To evaluate the features of diagnosis of amyloid cardiomyopathy (ACMP), differential diagnosis of different types of amyloidosis and its clinical manifestations. Materials and methods. Were analyzed 150 cases of patients who consulted at the
Externí odkaz:
https://doaj.org/article/5d30414e2f4a4ceab85c23c8c7cb79de
Autor:
Yihan Xiong, Gongcheng Qu, Xiaoyu Lu, Xin Chang, Miaoping Zhang, Jiantang Liang, Kexing Lin, Xiaoman Zhao, Xuejun Fu, Ying Huang, Qianhui Xu
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundHereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant inherited systematic disease primarily affecting the peripheral and autonomic nervous system, heart, eyes and kidney. Over 140 variants have been identified worldwide, wi
Externí odkaz:
https://doaj.org/article/ea00e47c242d4536860e9534cb4a85ba
Autor:
Maximilian Leo Müller, Ekaterina Latinova, Anna Brand, Isabel Mattig, Sebastian Spethmann, Daniel Messroghli, Katrin Hahn, Ulf Landmesser, Bettina Heidecker
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 14 (2024)
Background Results from ATTR‐ACT (Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy) indicate that tafamidis prolongs survival and reduces cardiovascular hospitalizations in cardiac transthyretin amyloidosis (ATTR‐CA)
Externí odkaz:
https://doaj.org/article/d5882afb77134ed4b953157ff190df27
Autor:
Nitin J. Burkule
Publikováno v:
Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, Vol 8, Iss 1, Pp 17-32 (2024)
Cardiac amyloid cardiomyopathy (CM) is a rapidly progressive disease that is frequently underrecognized and frequently diagnosed late in a significant number of individuals suffering from heart failure. Cardiac amyloid infiltration resulting in myoca
Externí odkaz:
https://doaj.org/article/0a83ffc3a6c24e12bf48e1754cc814f2